|
|
|
|
|
|
by netizen-936824
1610 days ago
|
|
|
As I stated in another comment, the study at hand was not about activity at CBRs 1 or 2. Plus when endogenous transmitters are concerned, these only stay in the local synapse. A pharmacological treatment has greater tissue distribution. If we want to effect cells that are exposed to a pathogen we need compounds that act at those cells We also don't know the mechanism of CBD preventing infection, this is only a preliminary study which shows that CBD has some effect through some mechanism. CBD's receptor profile has not been fully characterized afaik You seem to be jumping to an awful lot of conclusions |
|
|